Skip to main content
Kane Biotech
Global Pandemic
Biofilm R+D
Understanding Biofilms
Biofilm – Problem Areas
Our Facilities
Glossary of Terms
Sources
Technologies
Human Health
Animal Health
Industrial
About
About Us
Our Team
Awards
Careers
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Contact
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech - Q1 2017 Financial Reports
May 17, 2017
Kane Biotech - Business and Intellectual Property Update
May 11, 2017
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Mar 27, 2017
Kane Biotech Announces Completion of Share Consolidation
Mar 10, 2017
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
Mar 6, 2017
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Dec 21, 2016
Kane Biotech Announces Results of Special Meeting and Proposed Share Consolidation
Dec 16, 2016
Kane Biotech Announces Shareholder Meeting to Consider Share Consolidation
Nov 25, 2016
Kane Biotech Launches New Branding for StrixNB Oral Health Products for Dogs and Cats
Oct 19, 2016
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Sep 28, 2016
1
2
3
4
5
6
7
8
9
10
...20
